Localised prostate cancer and hemophilia A (AHA): Case report and management of the disease

  • Francesco Celestino | frapichi@libero.it Urologic Oncology Unit, Policlinico Casilino, Rome, Italy.
  • Cristian Verri Department of Experimental Medicine and Surgery, Tor Vergata University, Rome, Italy.
  • Francesco De Carlo Department of Experimental Medicine and Surgery, Tor Vergata University, Rome, Italy.
  • Savino Mauro Di Stasi Department of Experimental Medicine and Surgery, Tor Vergata University, Rome, Italy.

Abstract

Acquired Hemophilia A (AHA) is a rare bleeding diathesis characterized by the development of autoantibodies against factor VIII (FVIII). About half of the cases are idiopathic and the other half are associated with autoimmune diseases, postpartum problems, infections, inflammatory bowel disease, drugs, lymphoproliferative disorders or solid tumors . AHA is associated with malignancies in 7-15% of cases. We report a case of AHA in a 65 year old patient with prostatic carcinoma, who underwent retropubic radical prostatectomy (RP).

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.
Published
2014-09-30
Info
Issue
Section
Case Reports - Oncology
Keywords:
Activated partial thromboplastin time, Factor VIII, Hemophilia A, Prostate cancer, Radical prostatectomy
Statistics
  • Abstract views: 1593

  • PDF: 721
How to Cite
Celestino, F., Verri, C., De Carlo, F., & Di Stasi, S. (2014). Localised prostate cancer and hemophilia A (AHA): Case report and management of the disease. Archivio Italiano Di Urologia E Andrologia, 86(3), 227-228. https://doi.org/10.4081/aiua.2014.3.227